PHARMACY

CVS Health explores the ongoing transformation of community pharmacy
The Rx Report finds that 76% of consumers have had at least one active prescription for themselves or those they care for, and 79% have visited a pharmacy in the past year.
Sandoz releases generic Abraxane
The single-dose 100mg vial for intravenous use is FDA approved for metastatic breast cancer.

FDA gives Alembic nod for generic Lastacaft

Alcaftadine ophthalmic solution, 0.25% is used to temporarily relieve itchy eyes due to allergens.
Meijer touts success of Drug Take Back program

In 2024, Meijer customers have returned nearly 76,000 pounds of unwanted medications from proper disposal.
XiFin Pharmacy Solutions' webinar focuses on how the industry can propel pharmacy forward

The webinar highlighted how pharmacists, physicians, payors and legislators can collaborate to address physician and nurse shortages.
NACDS RAB Market Immersion in Chicago charts vision for future

Discussions centered on artificial intelligence, organized retail crime, reimbursement reform, real estate trends, retail media networks, innovation in retail and the state of wellness.
FDA approves Dong-A ST’s Stelara biosimilar

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis.
Biden administration releases preliminary list of $2 generic drugs for Medicare recipients

Participation in the model would be voluntary for Part D sponsors and, pending further development, could start as early as January 2027.
Teva’s Prolia biosimilar candidate accepted for review by FDA, EU EMA

Prolia is indicated to treat certain conditions that lead to high risk for fracture, including osteoporosis in postmenopausal women.
Glenmark pays $25M to resolve alleged False Claims Act liability for drug price-fixing

The government alleged that between 2013 and 2015, Glenmark paid and received compensation prohibited by the Anti-Kickback Statute.